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Abstract 
Medical implants are increasingly often inserted into bone of frail patients, who are 
advanced in years. Due to age, severe trauma or pathology-related bone changes, 
osseous healing at the implant site is frequently limited. We were able to demonstrate that 
coating of endosseous implants with nanocrystalline diamond (NCD) allows stable 
functionalization by means of physisorption with BMP-2. Strong physisorption was shown 
to be directly related to the unique properties of NCD, and BMP-2 in its active form 
interacted strongest when NCD was oxygen-terminated. The binding of the protein was 
monitored under physiological conditions by single molecule force spectroscopy, and the 
respective adsorption energies were further substantiated by force-field-calculations. 
Implant surfaces refined in such a manner yielded enhanced osseointegration in vivo, 
when inserted into sheep calvaria. Our results further suggest that this technical 
advancement can be readily applied in clinical therapies with regard to bone healing, 
since primary human mesenchymal stromal cells strongly activated the expression of 
osteogenic markers when being cultivated on NCD physisorbed with physiological 
amounts of BMP-2. 
Keywords: nano-crystalline diamond (NCD), physisorption, bone morphogenetic 
protein-2 (BMP-2), bone regeneration, mesenchymal stem cells 
Introduction 
Only recently, the exceptional properties of diamond have been recognized to be not only 
of advantage in tool industry or tribology, but more than that it may also lead to improving 
advances when applied in life science, sensor technology or electronics. The deposition 
of thin films of nanocrystalline diamond (NCD) onto materials leaves the overall texture of 
specimen greatly unchanged while allocating a variety of properties of natural diamond to 
the substrate surface. Yet due to the nanotopography of NCD, the resulting surface is 
enlarged and in combination with further refinement, such as the termination of the 
dangling bonds of the carbon atoms, proliferation and differentiation of cells can be 
influenced in a controlled manner [1, 2]. Because the NCD surface is open to additional 
complex chemical refinement, it became conceivable for us to design medical implants 
that allow stable binding of molecules, such as bone morphogenetic protein-2 (BMP-2) [3, 
4]. BMP-2 is capable of ectopic bone formation and has been approved for clinical use [5, 
6]. In physiological settings, BMP-2 exerts its effects in nanogram doses [7], yet due to 
release from its site of application the recommended amounts applied to date are around 
25 mg depending on the respective therapeutic regimen [5, 6]. Taking this into account 
and in order to prolong the effect of freely-diffusible growth factors, slow releasing 
systems have been put to test [8-10]. This way of practice however still incurs the risk of 
adverse effects, which in particular may affect the vascular system [11] or the immune 
system [12]. In an attempt to overcome these limitations we could demonstrate only 
recently that BMP-2 binds to oxygen-terminated NCD (O-NCD) in a highly stable, 
non-covalent manner, a procedure also known as physisorption [3]. In the present 
investigation we further corroborated these findings by performing detailed analytical 
measurements using atomic force microscopy (AFM). Moreover, by carrying out in depth 
theoretical modeling, we attempted to apprehend the nature of the protein-NCD 
interaction at the atomic level. The effect of BMP-2 physisorbed to H- or O-terminated 
NCD was further tested in vivo by inserting implants into sheep calvaria. In order to extend 
our results from the animal experiment to the human system, we finally studied the 
osteogenic differentiation potential of primary human mesenchymal stromal cells grown 
on BMP-2 treated O-NCD covered implant surfaces as a substrate. The results presented 
in this contribution greatly suggest that this novel technique may be safely adopted for 
routine clinical therapies in the near future. 
Material and Methods: 
Theoretical calculation: 
The three-dimensional structure of the BMP-2 homo-dimer [13] together with diamond as 
used in the present study was inapplicable as an input for quantum mechanical methods 
such as Density Functional Theory. Therefore, methods of classical molecular mechanics 
based on parameterized force fields were applied to overcome the problems with the size 
restrictions of quantum mechanical methods. The applied NCD-films show mainly (111) 
and (100) surface planes examined with xray diffraction. Reactivity of the (111) and (100) 
planes are known to behave equivalent with regard to adsorption. Theoretical calculations 
have shown that the bulk-diamond (100) surface is ideal to use for the present type of 
investigation [14]. Working along these lines and taking into account empirical data for 
molecules in isolation structural determinants at the atomic level were approximated 
resulting in simulations of thousands of atoms over nanoseconds of time and reliable 
predictions of a variety of physical properties. The ab initio force field (COMPASS 
(Condensedphase Optimized Molecular Potentials for Atomistic Simulation Studies; 
Accelrys, Inc., San Diego, USA)) was applied for an accurate and simultaneous prediction 
of structural properties for a broad range of molecules in isolation and in condensed 
phases as well as under a wide range of conditions of temperature and pressure was 
applied. The atomic charges were force field assigned in calculations with ultra-fine 
quality, with threshold values for optimization parameters such as energy, force and 
atomic displacement of 8.4 x 10
-5
 kJ/mol, 0.04 kJ/mol/nm and 1.0 x 10
-6
 nm, respectively. 
The summation method was atom based. Because the surface of many medical implants 
is composed of pure titanium or TiO2. and secondly in order to outline any qualitative 
effect taking place upon binding, the interaction of a BMP-2 homo-dimer with titanium, 
anatase and rutile in its (001) plane was modeled first. O-NCD was expected to be 
superior to H-NCD [3], in particular with regard to BMP-2 surface bond strength at higher 
temperatures as well as for various surface concentrations of OH, and because the 
BMP-2/surface bond strength at room temperature and/or interfacial geometry will follow 
the calculated trend of bond energy, the calculations were performed at zero Kelvin, thus 
omitting the temperature dependent part (entropy, ΔS) of the free energy, ΔG: 
ΔG = ΔHbinding+ ΔHconformation − T (ΔSrot  trans +ΔSflex + ΔSsolvatation) (Equation 1) 
leading to the following interaction energy as base for the theoretical calculation: 
ΔH = Hsurface-dimer – (Hsurface – Hdimer)     (Equation 2) 
where Hsurface-dimer, Hsurface and Hdimer are the energies for the total complex and the 
reactants prior to the attachments. The interaction energy, ΔH, was divided into different 
terms depending on the type of bonding between the diamond surface and the BMP-2 
homo-dimer: van der Waals (including H-bonds) and electrostatic energies. 
Preparation of the heteroepitaxial (001) diamond layer: 
Deposition of epitaxially oriented diamond grains on a silicon (001) single crystal 
substrate was done in a microwave plasma chemical vapor deposition (CVD) setup at a 
substrate temperature of 780°C, a microwave power of 1300 W and a gas pressure of 45 
mbar. Oriented nucleation was induced by the bias enhanced nucleation procedure 
applying a negative voltage of - 210 V to the silicon substrate for 5 minutes in a gas 
mixture of 9% methane in hydrogen. During 18 hours growth, the process gas contained 
7.5% methane and 1.25% carbon dioxide in hydrogen. The diamond surface was 
terminated with oxygen by thermal post-processing at 400°C for 4 hours with 21% 
oxygen. 
Preparation of nanocrystalline diamond (NCD) surfaces: 
Deposition of randomly oriented NCD films (500 to 800 nm thick and grain sizes of 5 to 20 
nm) on titanium dental implants (length: 6 mm, diameter: 4.8 mm, surface topography: 
sandblasted, large grit and acid-etched (SLA) Straumann AG, Basel, Switzerland) was 
carried out as described recently [1]. The precursor gas was 3% methane in hydrogen. 
Nucleation was induced by ultrasonic mechanical seeding procedure. Eventually, the 
dangling bonds at the highly hydrophobic native NCD-surface (H-NCD) with a contact 
angle of ~120° were terminated with oxygen by thermal post-processing at 400°C for 4 
hours with 21% oxygen, rendering the NCD-surface hydrophilic (O-NCD) (contact angles 
< 10°).  
Physisorption of BMP-2: 
BMP-2 (human, E.coli expressed, R&D, Minneapolis, USA) was dissolved in deionised 
water following the manufacturer’s recommendation. NCD-coated substrates 
(heteroepitaxial diamond (001)) were incubated with BMP-2 (1 µg/mL) for 90 minutes in a 
humidified chamber. Subsequently, treated substrates were carefully rinsed with 
de-ionised water or phosphate-buffered saline (PBS).  
AFM imaging: 
Topographical images were acquired with the aid of a Pico Plus AFM equipped with a 
MACmode controller (Agilent Technologies, Tempe, AZ). Measurements were performed 
in PBS, pH 7.4  using a magnetically coated Cantilever (Agilent Technologies, Tempe, 
AZ) with a nominal force constant of 0.1 N/m. 
AFM force spectroscopy: 
The effective binding force of BMP-2 under physiologic conditions with respect to HNCD 
and O-NCD surfaces was quantitatively assessed using single molecule force 
spectroscopy. BMP-2 was tethered to amino-functionalized silicon nitride AFM tips with a 
force-constant of 0.03 N/m (Veeco, Dourdan, France) via 
aldehyde-polyethylenglycol-N-hydroxysuccinimide as described previously [15]. The AFM 
tip with PEG-linked BMP-2 was approached and subsequently retracted with a velocity of 
300 nm/s, and the deflection traces were recorded and transformed into force versus 
distance curves. As physisorption of BMP-2 is assumed being a stochastic process, 
statistical analysis of 1000 force-versus-distance curves on each surface (4 different 
positions per surface) were carried out. From each force-versusdistance curve, the 
unbinding force and the variance of the measuring noise (fluctuation of the baseline) were 
taken (as the mean and the variance) to generate a Gaussian distribution representing a 
single force value broadened by the intrinsic measurement noise. The experimental 
probability-density function was calculated by summing up the Gaussian distributions and 
the result was normalized with respect to the overall number of recorded curves [16]. 
Surgical procedure and post operational treatment: 
Six healthy, 4 year-old female sheep weighing 70 ± 5 kg were fasted overnight while 
having free access to water. 0.5 mg atropine was administered and anaesthesia was 
induced with ketamin (Ketavet
®
 7-8 mg/kg body weight). After fiberoptic intubation during 
spontaneous respiration, the sheep were ventilated with a volume controlled ventilator 
(Draeger EV-A, Lübeck, Germany) with 35% O2/air at 14-18 breaths/minute and a tidal 
volume of 800 mL. Anaesthesia was maintained with Isoflurane (Forane
® 
, Abbot, Vienna, 
Austria) and Ringer's solution (6 mL/kg/hr) was administered continuously throughout the 
operation to replace fluid loss during the surgical procedure. A sagittal incision was 
performed on the forehead to access the frontal bone. Twelve implant beds with a depth 
of 8-9 mm were prepared. During trepanation, special care was taken that the depth of the 
wound exceeded the implant length by 2-3 mm. This allowed us to follow bone healing 
within the set wound together with de novo bone formation, the latter taking place directly 
at the apical site of the implant surface. The implants (Straumann AG, Basel, Switzerland) 
with and without NCD (rho-BeSt coating GmbH, Innsbruck, Austria) were distributed 
randomly, resulting in the following experimental groups: SLA titanium (control), H-NCD, 
O-NCD, H-NCD/BMP and O-NCD/BMP. After 3 days, 1 week and 4 weeks, two animals of 
each experimental group were sacrificed. Taken together five implants per experimental 
group and four implants of the control group at each time point were evaluated in detail. 
Bone specimens together with the inserted implants were embedded into Technovit 9100 
neu (Heraeus Kulzer, Hanau, Germany). After embedding, specimens were bisected and 
one half was subjected to immunohistochemical analysis, while the other half underwent 
cutting-grinding resulting in 3 samples per specimen. The latter preparations were 
subsequently stained with Toluidine Blue O and the bone-to-implant contact ratio (BICR) 
as previously defined as the length of bone surface border in direct contact with the 
implant [5] was assessed for 15 different samples per time point and experimental group. 
However, BICR was solely determined at that surface lining, which prior to healing faced 
the open cavity. Hence only regions of de novo bone formation at the implant surface 
were taken into consideration. Immuno-histochemistry was performed using anti-BMP-2 
antibody (H-51, rabbit polyclonal IgG; Santa Cruz Biotechnology Inc., Santa Cruz, CA) 
and a HRP-labeled anti-rabbit IgG followed by ACE+ staining (DAKO, Glostrup, 
Denmark).  
Cell Culture:   
Human bone-derived primary mesenchymal stromal cells (MSC) exhibiting osteogenic 
differentiation potential were cultivated on O-NCD-coated titanium that had been treated 
with BMP-2 in a manner comparable to the medical implants. MSC were isolated from the 
iliac crest of systemically healthy individuals, which had been harvested for reconstructive 
bone surgery of defects within other areas of the body as described previously [17]. Briefly, 
a small biopsy of substantia spongiosa osseum, which otherwise would have been 
discarded based on necessary bone for molding and re-contouring prior to insertion into 
the recipient site was taken to further investigation under an Institutional Review 
Board-approved protocol after having obtained patients’ written consent. After surgery, 
the bone was transferred into modified eagles medium (MEM) supplemented with 20% 
fetal calf serum (FCS), 100 units/mL penicillin, 100 µg/mL streptomycin, for transportation 
from the operation theatre to the clean room at room temperature. The biopsies were 
fragmented and marrow cells were isolated from pieces (20-100 mm
3
) by centrifugation 
(400 x g, 1 minute). After centrifugation, the remaining pieces were treated with 
collagenase (2.5 mg/mL in MEM) for 2 hours at 37°C, 20% O2 and 5% CO2. Thereafter, 
the specimen was again centrifuged (400 x g, 1 minute). Cells were resuspended and 
loaded on a Ficoll-Paque Plus® gradient and centrifuged at 2,500 x g for 30 minutes. Cells 
were harvested from the interphase (density <1.075 g/mL), washed and collected by 





 at 5% CO2 and 37°C (Heraeus, HeraCell 240). After 24 hours, the nonadherent 
cell fraction was removed by washing twice with PBS. After the primary culture had 
reached approximately 30 – 50% confluence, cells were washed twice with PBS, and 
subsequently treated with 0.05% trypsin / 1 mM EDTA for 3 – 5 minutes at 37°C. Cells 
were harvested, washed once in MEM and further expanded at a density of 50 cells/cm².  
RNA preparation and quantitative Reverse Transcription-Polymerase Chain Reaction 
(qRT-PCR): RNA was isolated from cells after homogenisation in 4.2 M guanidinium 
thiocyanate, phenol extraction and ethanol precipitation [17]. For qRT-PCR, cDNA was 
synthesized from total RNA using RevertAid H Minus-MMuLV-RT (Fermentas, St. 
Leon-Roth, Germany) and oligo(dT) primer (MWG, Germany). The assays were 
performed on a LightCycler instrument (Roche, Austria) with the LC-FastStart DNA 
Master SYBR Green I Kit (Roche, Austria). The 15 μL reactions contained 2 μM forward 
and reverse primer and 3 mM MgCl2. After the activation of the enzyme at 95°C for 8 
minutes, 50 cycles at 95°C for 15 seconds, 57°C for 8 seconds and 72°C for 15 seconds 
were performed. mRNA expression levels were calculated relative to eukaryotic 
translation elongation factor 1 alpha 1 (EEF1A1). Primer sequences and transcript IDs of 
the corresponding genes were as follows: SPARC/osteonectin (ENST00000231061) 
5’-TCCCTGTACACTGGCAGTTC-3’ / 5’-TCCAGGTCACAGGTCTCG-3’; 
PMF1/osteocalcin (ENST00000368272) 5’-ACACTCCTCGCCCTATTG-3’ / 
5’-TCCTGCTTGGACACAAAG-3’, SPP1/osteopontin (ENST00000237623 / 
ENST00000359072 / ENST00000360804) 5’-ATGGCCGAGGTGATAGTG-3’ / 
5’-CATTCAACTCCTCGCTTTC-3’; IBSP/bone sialo protein-2 (ENST00000226284) 
5’-CCGAAGAAAATGGAGATGACAG-3’ / 5’-CCATAGCCCAGTGTTGTAGCA-3’; 
EEF1A1/elongation factor 1-alpha (ENST0000309268 / ENST0000316292 / 
ENST0000331523) 5’-CAAGTGCTAACATGCCTTGGT-3’ / 5’- 
GAACAGTACCAATACCACCAATTT-3’.   
Statistics 
Data were statistically analysed using paired Student´s t test. Analyses were performed 
with SPSS (vs 15, SPSS Inc., Chicago, IL). The tests were two-sided with type 1 error 
probability of 0.05. Data are presented as mean values ± SD. 
Results  
Theoretical Calculation:  
The sum of the van-der-Waals and electrostatic interactions for different titanium 
substrates exhibited endothermic values (>0 kJ/mol) for all these compounds in the 
following order of decreasing endothermicity: TiO2(anatase)>TiO2(rutile)>Ti. This 
indicates that a BMP-2 homo-dimer will not bind to titanium surfaces. Regarding unrefined 
NCD (H-NCD), and O-NCD, our model assumed that besides van-der-Waals forces and 
H-bonds, also electrostatic interactions between the surface and BMP-2 account for 
binding. Under physiological conditions a water adlayer is present at NCD surfaces, which 
greatly influences the surface polarity and thus its degree of hydrophilicity [18]. Given that 
the diamond surface is completely terminated with OH and covered by a water adlayer 
(Figure 1), we calculated that the BMP-2 homo-dimer adsorbs in a highly exothermic 
reaction of about -850 kJ/mol, whereby the electrostatic interactions are contributing 
approximately 75%. In the case of H-NCD, BMP-2 binds only at a rate of about -250 
kJ/mol (electrostatic interaction: 80%). Notably in both situations, due to the presence of 
the thin water interlayer, the adsorption energy changed by about - 200 kJ/mol.  
AFM imaging and force spectroscopy:  
AFM imaging was applied to reveal experimental evidence about the conformational state 
of BMP-2 when physisorbed onto O-NCD. This was feasible, because the (001) facets of 
heteroepitaxially oriented diamond crystallites are rather smooth (Figure 2A) so that 
single BMP-2 molecules could be clearly resolved using the AFM-technique [19]. Due to 
the size and morphological appearance, approximately 90 percent of the bound entities 
were distinguished as dimers (Figure 2 B,C). We furthermore experienced that bound 
BMP-2 was not removed, when directly touched with the AFM tip, even not when single 
molecules had been imaged for several times. The interaction of BMP-2 with NCD 
surfaces was directly probed in force-versus-distance curves using AFM tips 
functionalized with BMP-2. BMP-2 showed strong interaction with O- and H-terminated 
diamond, whereas virtually no binding was observed on glass (Figure 3 A). A statistical 
validation of 1000 force-versus-distance curves yielded experimental 
probability-density-functions (pdfs) for unbinding forces. The latter were characterized by 
the most probable unbinding forces (maxima of pdfs’) and their corresponding standard 
deviations. The interaction forces of 49.3 ± 20 pN were larger for O-terminated diamond 
compared to 38.2 ± 30 pN for H-terminated diamond (Figure 3B). Furthermore, the 
number of force-versus-distance curves containing a binding event (expressed as binding 
probabilities when normalized to the total number of force-versus-distance curves) of 
BMP-2 on O-terminated diamond was higher than on H-terminated diamond. With glass, 
only little interaction was observed (Figure 3 C). 
Osseointegration of BMP-2-treated, NCD-coated implants:  
In light of these results, we evaluated NCD with and without physisorbed BMP-2 in vivo. 
After three days, all wounds showed a high degree of hematoma. Using a specific 
antibody, which discriminates between ovine and recombinant BMP-2 in 
immuno-histochemical analysis, we examined both exogenous and endogenous BMP-2. 
Within developing bone and in the periost, BMP-2-like reactivity was detectable in all 
experimental groups (Figure 4). However, only in the case of O-NCD/BMP-covered 
implants, BMP-2 was also found right adjacent to the implant surface after 3 days and 1 
week, presumably due to physisorbed BMP-2 delivered to these sites. One week post 
operation, cell numbers increased in the vicinity of those implants, which exposed SLA 
titanium, O-NCD as well as O-NCD/BMP and H-NCD/BMP to the wound, yet not in the 
case of H-NCD-coated implants. H-NCD/BMP implants performed comparable to SLA 
titanium or O-NCD (Figure 4). In the surrounding of those cells, which had migrated into 
the space between bone and implant, decent amounts of BMP-2 were detectable (Figure 
4). In the case of ONCD/BMP, not only high levels of BMP-2 were detectable in the cleft 
region, more than that, a higher number of putative osteoblasts were found in tight contact 
with the implant (Figure 4). These characteristic cells together with extracellular matrix 
(ECM) in close vicinity to the implant distinctively resembled early bone formation. 
Although BMP-2 was detectable in all experimental groups, the level of BMP-2 juxtaposed 
to O-NCD/BMP-coated implants was remarkably high, greatly suggesting that also in vivo 
BMP-2 remained physisorbed to O-NCD over a prolonged period. 4 weeks post operation, 
new bone was formed at the apex of the implant in all groups. BMP-2 levels at 
implantation sites were comparable to those of the surrounding osseous tissue. 
 
One week post operation and Toluidine Blue O staining, in all specimens no gross 
histological differences were evident at sites of newly forming bone. However 4 weeks 
post operation, clear anatomical differences at the apical surface of the implant became 
apparent. Parts of the surface of SLA titanium, H-NCD and H-NCD/BMP were covered 
with accumulating fibrous tissue, whereas in the case of O-NCD/BMP, the implant was 
overlaid with a thick layer of mineralized osseous tissue (Figure 5). To rate the efficacy of 
de novo bone formation at the implant surface, the bone-implant-contact-ratio (BICR) was 
assessed (see graph depicted in Figure 6 A). When comparing O-NCD to SLA titanium 
implants as a control, BICR was increased, and it was even higher in the case of 
O-NCD/BMP. For H-NCD implants both with and without BMP-2, BICR was decreased. 
However, we also recognized that more bone mass was formed adjacent to O-NCD/BMP 
covered implants (Figure 6 B). 
 
Osteogenic induction of human mesenchymal stromal cells: 
After 7 days in culture, osteogenic differentiation was evaluated by monitoring the 
expression of molecular markers, such as the pre-osteoblastic protein, SPARC 
(osteonectin), IBSP (bone sialoprotein-2), as well as PMF1 (osteocalcin) and SPP-1 
(osteopontin). In a first set of experiments, SPP-1 was found to be induced strongest 
(Figure 7A). In a subsequent series of experiments, increasing concentrations of BMP-2 
were physisorbed to O-NCD prior to MSC cultivation. SPP-1 expression was activated in 
a concentration-dependent manner in those MSC, which had been cultured on 
O-NCD/BMP, while in those MSC, which were grown on plastic in the same culture well 
next to the test substrate, SPP-1 expression remained largely unchanged (Figure 7 B). 
This is indicative for BMP-2 remaining tightly bound to ONCD and after physisorption, if at 
all, only a minor amount appears to be freely diffusible in its active form. Interestingly 
however, MSC cultured on plastic adjacent to the O-NCD-coated substrate, which had 
been physisorbed with 1.5 µg/mL BMP-2, showed an increase in SPP-1 expression. This 
effect might be due to excessive BMP-2, which became released from the surface after 
initial physisorption. 
Discussion:  
Endosseous implants are widely used because they effectively support the functional and 
aesthetic rehabilitation in orthopaedics and maxillo-facial surgery. Although most implant 
types have been applied in several areas with high efficacy, the surface properties of 
endosseous implants were continuously improved over the last years in order to optimize 
healing performance as well as endurance within the patient’s body. In this context it is 
important to point out that the patients’ mean age, when receiving endosseous implants 
constantly increased during the previous years and for that reason, poor implant site 
conditions, which in many cases are due to age-associated bone changes became a 
more prevalent problem for therapeutic strategies [20]. Growth factors such as members 
of the BMP family are being applied in the clinics, in particular to improve bone healing in 
problematic trauma cases [5, 6, 21] as well as in reconstructive surgery [22]. Due to the 
fact that these growth factors are still administered in a rather crude fashion, the 
recommended dosages are far higher from those considered to be present under normal 
physiological conditions. Thus as a consequence unwanted systemic effects are possible 
[12]. These emerging problems can only be overcome by refining the method of 
application, e.g. by immobilizing drugs in cases where implants are used. Potential 
immobilization techniques are covalent binding or adsorption [9, 23-26]. Both techniques 
however exhibit considerable obstacles in a clinical setting. Covalent binding without 
complex chemistry in various sequential steps of protection and deprotection, which favor 
growth factor binding and minimize protein-protein crosslinking is hard to achieve by 
those who prepare for or perform surgery [24]. Alternatively, proteins may be immobilized 
to the surface of implants by adsorption. To date, many implant types are made of titanium 
or related alloys. These materials however exhibit only low to no protein adsorptive 
properties [9, 24]. A simple solution to this problem could be structural refinement or 
coating of the surface with a layer of biocompatible material, which also binds 
biomolecules tightly. In line with this, we have only recently demonstrated that BMP-2 
tightly binds to O-terminated NCD and physisorbed BMP-2 remains bioactive [3]. As 
assumed in this contribution, it appears likely that binding of BMP-2 to NCD preferentially 
occurs in an energetically minimized state, which concomitantly would not alter the 
protein’s conformation. Opposed to that, no favorable interactions could be observed in 
the case of titanium both when performing modeling or physical assessments of 
interaction forces. This is in accordance with a report that certain nano-biomaterials do 
exhibit surface properties that support protein binding and more than that, could also be 
applied to sustain particular biological functions of cells [27]. Proteins may unfold when 
adsorbed on nanostructures compared to microstructures [28]. Adsorption to 
nano-biomaterials is firstly determined by a greatly enlarged surface-to-volume-ratio, 
which secondly specifies surface energy [26]. In the case of NCD, surface energy is 
furthermore established by exposition of defined characteristics of its termination, which in 
due course effectuates the adsorptive properties of the material. This issue can be 
addressed by modeling and employing theoretical calculations. For O-NCD, we observed 
that van-der-Waals forces, H-bonds and electrostatic interactions contribute to the 
accumulating binding forces. As a consequence, BMP-2 exhibits stronger binding 
energies on O-NCD compared to H-NCD. 
 
Binding of biomolecules most often takes place in an aqueous environment, thus the 
effect of an water adlayer was included into the present calculations. Moreover, 
functionalized NCD surfaces appear to strongly bind water molecules. BMP-2 binding 
towards H- and O-terminated surfaces was therefore calculated in conjunction of a stable 
water adlayer present at the surface [28], and taking this into account, for BMP-2 on 
OH-terminated diamond the binding energies of - 859 kJ/mol were estimated. Binding of 
BMP-2 when adsorbed on OH-terminated diamond can therefore be regarded as strong 
as if BMP-2 would have been attached in a covalent fashion. These considerations could 
be confirmed by means of AFM. The unbinding forces together with the overall binding 
probabilities of physisorbed BMP-2 on O-NCD were significantly higher compared to 
H-NCD.  A conclusive proof of whether BMP-2, when being physisorbed to NCD is still 
capable of inducing ectopic bone formation is only offered by performing in vivo animal 
experiments [29-31]. Still it is poorly understood whether ECM acts as a buffer and due to 
slow release of BMP-2 a chemotactic gradient is being established, or whether cells solely 
respond to BMP, which is bound to components of the ECM and therefore is being 
presented in a complexed fashion to the corresponding surface receptor molecules [30]. 
This in mind, NCD-coated titanium was physisorbed with BMP-2 prior to engraftment into 
freshly injured bone. Intentionally, the apical site of the implant was not brought in direct 
contact with bone. Thereafter the effect of differently refined NCD with or without bound 
BMP-2 with respect to induction of bone formation was assessed. Notably, since 
physisorption was carried out with 1 µg/mL BMP-2, only sub microgram amounts of the 
growth factor were eventually introduced into the wound. This is in sharp contrast to the 
extent applied in the current clinical approaches. 
 
One week after insertion, BMP-2 appeared to be solely present at those implant surfaces 
which were coated with O-NCD, strongly suggesting that stable binding of BMP-2 only 
took place on O-NCD and further persisted under in vivo conditions. This finding is 
consistent with what has been proposed by means of the theoretical calculations and had 
been measured with aid of AFM in vitro. Furthermore, the number of preosteoblasts in 
conjunction with collagen fibres, which were found in the wound bed at the basal part of 
the implant was increased. After 4 weeks after implantation this circumstance also yielded 
statistically significant elevated rates of BICR.in the case of O-NCD treated with BMP-2 
when compared to O-NCD coated implants alone. This observation however implies that 
the effect was not entirely due to the activity of BMP-2 since O-NCD on its own, still 
improved healing when comparing the results of all experimental groups. These findings 
are in concordance with recent data, assuming that the positive effect of hydrophilic 
surface properties of implanted material exert a positive effect on osseointegration [32, 
33]. Sufficed to say that O-NCD physisorbed with BMP-2 yielded the best results 
concerning the bone formation at the apex of the implant, it should be pointed out in this 
context that regardless of whether BMP-2 had been physisorbed to implants prior to 
insertion, H-NCD showed statistically significant decreased levels with respect to O-NCD 
and O-NCD treated with BMP-2 by resulting in a low BICR as well as in elevated levels of 
fibrous tissue formation adjacent to the implant. Notably, this effect was not found 
reverted in the case of BMP-2 treated H-NCD. This observation together with the results 
obtained after theoretical calculations and AFM measurements, suggest that only trace 
amounts of BMP-2 may bind to H-NCD and are most likely detaching from the implant 
surface soon after insertion.  
As a first step in an attempt to translate these findings into a clinical application, we 
employed human primary MSC, which had been derived from bone of healthy individuals. 
In vitro these cells firmly attach to the surface of cell culture plastic, and there grown as a 
monolayer, MSCs can be efficiently induced by bioactive factors, e.g. BMP-2 to 
commence differentiation into osteoblasts. These particular cellular derivatives of MSC 
express specific molecular markers and also deposit characteristic ECM components 
together with high levels of calcium. These cells would normally also sense increasing 
doses of soluble BMP-2, which in due course results in a seemingly increased expression 
of various bone matrix proteins [34]. When we cultivated MSCs on O-NCD together with 
BMP-2, a variety of molecular markers was activated. More than that, increasing amounts 
of BMP-2 resulted in a steady rise of the SPP-1 expression reaching a plateau when 
BMP-2 greater than 1 µg/mL had been physisorbed onto O-NCD. In the latter case, MSCs 
cultivated next to the NCD substrate also showed upregulation of SSP-1, which could well 
be due to BMP-2 released into the culture medium. In conclusion, protein binding to 
chemically refined NCD surfaces could be accurately monitored by means of AFM. Using 
that technique, we were able to rapidly assess the relative binding strength at the 
single-molecule level. Applied in future work, this regimen therefore eases further 
advancements of NCD surface refinement, in particular when designing specifically 
desirable surface properties with regard to binding of distinct proteins. Working along 
these lines, it became clear that BMP-2 stably immobilizes to NCD surfaces by 
physisorption. It appears highly likely that bone implants, which are functionalized in such 
a manner, can be safely applied for clinical purposes without implying the risk of adverse 
systemic side effects, because BMP-2 administered in this manner solely exhibit 
short-distance effects and thus enhances bone healing right at the implant sites. Due to 
the fact that biologically active factors can be easily immobilized by such means, 
appropriately low doses of bioactive factors are sufficient to yield the desirable biological 
effect. Accordingly, the use of expensive drugs in daily clinical life, e.g. cytokines, growth 
factors as well as other high-molecular-weight substances becomes affordable and most 
important in this context also safe. We therefore anticipate that implant surfaces when 
custom-tailored by NCD-coatings, provide a potential basis for implant functionalization 
with bioactive molecules.  
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Figure Caption:  
Figure 1: Model of terminated diamond / BMP-2 homo-dimer interaction  
Physisorbed BMP-2 remained active and exhibited high stability of binding sites without 
deforming the geometry and structure of the protein due to the relaxed position in 
adherent, energetically minimized state. Since the attachment of homodimer BMP-2 
molecules has experimentally been observed to involve dimers in a position of about 3 nm 
above the diamond surface, a corresponding model for the force field calculation was 
applied. A thin water adlayer as expected on solid surfaces was integrated into the 
calculations. The resulting geometries for BMP-2 homo dimer on water-containing 
interfaces based on H- and OH-terminated diamond surfaces, are demonstrated in this 
figure: top: BMP-2 homo dimer on H-term. + water adlayer, bottom: BMP-2 homo dimer on 
OH-term. + water adlayer.   
Figure 2: Atomic force microscopy of BMP-2 physisorbed onto heteroepitaxial 
diamond film  
(A) Topography of bare heteroepitaxial diamond film at a cross-section depicted by the 
green line is displayed by the graph below. The surface was monitored at higher 
resolution before (A, B) and after (C) BMP-2 physisorption (false-color code is valid for 
both B and C). (D) 3-dimensional representation featuring the dimeric structure of bound 
BMP-2. The graph in the lower part of the panel displays the z-plane of the 
cross-sectioned area depicted by the green line.  
Figure 3: Monitoring of binding forces by AFM force spectroscopy  
(A) Using a BMP-2-functionalized AFM tip (aldehyde PEG linker), force spectroscopy was 
performed by recording force-versus-distance curves on (I) O-terminated diamond, (II) 
H-terminated diamond, and (III) glass. The red line shows the course of approaching the 
surface; the blue depicts the force upon retraction of the AFM tip. At a distance of ~15 nm, 
which corresponds to the length of the stretched BMP-2/PEG conjugate, the protein 
unbinds from the surface with a force specific for the particular surface. The parabolic 
shape of the force curve before unbinding reflects the viscoelastic properties of the PEG 
linker. (B) Unbinding force distributions obtained for O-diamond (solid line), H-diamond 
(dashed line), and on glass (dash-dotted line) were acquired in PBS at room temperature. 
Probability density functions (pdf) were calculated on the bases of 1000 
force-versus-distance measurements at 4 different positions of every specimen. (C) 
Histogram of the overall binding probabilities. Error-bars indicate standard deviations 
obtained from measurements on different surface positions.   
 
Figure 4: BMP-2 immune histochemistry after NCD implantation into bone  
Representative examples of immune-histochemical preparations derived from 3 days and 
1 week post operation specimen, which had been reacted with an antibody detecting both 
human and ovine BMP-2. Regions adjacent to the apical site of the implant as highlighted 
in the scheme depicted at the upper left part of the panel are shown for titanium, 
hydrogen-NCD (H-NCD), and oxygen-terminated NCD (O-NCD). The latter was 
furthermore treated with 1 µg/mL BMP-2 (/BMP) prior to insertion into sheep calvarias.   
Figure 5: Histology of bone healing after implantation of BMP-2 coated NCD 
According to the depicted scheme at the left side of the panel, representative examples 
of Toluidine Blue O stained bone sections are presented. Specimens from all 
experimental groups (3 days, 1 and 4 weeks post operation) were processed by the 
cutting-grinding method. Connective tissue (c) adjacent to the implant was observed at 
titanium, H-NCD and H-NCD/BMP. Bars indicate 200 µm.  
Figure 6: Determination of bone-implant-contact-ratio after healing  
Bone-implant-contact-ratio (BICR) was only determined at the apical surface of the 
implant opposing the area of regeneration as shown in the diagram at the lower left site 
of the panel (A) and for those specimens that were derived from experimental animals, 
4 weeks after implant insertion (B).  
Figure 7: Induction of osteogenic markers in MSC cultured on NCD  
(A) Transcriptional activation of osteogenic markers in mesenchymal stromal cells, 
which were cultivated for 7 days on O-NCD that had been functionalized with 1 µg/mL 
BMP-2; SPARC: osteonectin, PMF1: osteocalcin, SPP-1: osteopontin, IBSP: bone 
sialoprotein 2. (B) Induction of SPP-1 in mesenchymal stromal cells, which were 
cultivated either on substrates functionalized with increasing amounts of BMP-2 (filled 
columns) or adhering on the plastic in the culture well adjacent to the NCD-coated 
substrates (open columns). All values were expressed as means ± standard error of the 
mean. Differences were considered significant when p as determined by a paired, 
two-sided Student’s t test was less than 0.05.  
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